Does USTEKINUMAB Cause Sars-cov-2 test positive? 106 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 106 reports of Sars-cov-2 test positive have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.1% of all adverse event reports for USTEKINUMAB.
106
Reports of Sars-cov-2 test positive with USTEKINUMAB
0.1%
of all USTEKINUMAB reports
1
Deaths
22
Hospitalizations
How Dangerous Is Sars-cov-2 test positive From USTEKINUMAB?
Of the 106 reports, 1 (0.9%) resulted in death, 22 (20.8%) required hospitalization, and 4 (3.8%) were considered life-threatening.
Is Sars-cov-2 test positive Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 106 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Sars-cov-2 test positive?
OCRELIZUMAB (1,421)
ADALIMUMAB (1,301)
DUPILUMAB (860)
NIRMATRELVIR\RITONAVIR (538)
LENALIDOMIDE (469)
SECUKINUMAB (378)
CERTOLIZUMAB PEGOL (361)
RISANKIZUMAB-RZAA (335)
RITUXIMAB (305)
UPADACITINIB (281)
Which USTEKINUMAB Alternatives Have Lower Sars-cov-2 test positive Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE